Inci Alican

Prof. Inci Alican


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2007 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MKMeltem Kolgazi
Meltem Kolgazi
NJNermina Jahovic
Nermina Jahovic
MYMeral Yüksel
Meral Yüksel
FEFeriha Ercan
Feriha Ercan
IAInci Alican
Inci Alican

27 May 2009 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
SISevgin Ozlem Iseri
Sevgin Ozlem Iseri
YEYasemin Ersoy
Yasemin Ersoy
FEFeriha Ercan
Feriha Ercan
MYMeral Yuksel
Meral Yuksel
PAPınar Atukeren
Pınar Atukeren
IAInci Alican
Inci Alican

1 January 2006 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
NJNermina Jahovic
Nermina Jahovic
NGNursal Gedik
Nursal Gedik
FEFeriha Ercan
Feriha Ercan
SŞSerap Şirvanci
Serap Şirvanci
MYMeral Yüksel
Meral Yüksel
IAInci Alican
Inci Alican
Objective. The results of previous studies suggest that statins have a direct anti-inflammatory effect that is not directly related to their cholesterol-lowering activity. The aim of this study was to investigate the effect of simvastatin (SIM) and fluvastatin (FLU) on trinitrobenzene sulfonic acid (TNBS)-induced colonic inflammation in rats. Material and methods. The drugs were given for 3 days (0.1 and 1 mg/kg day−1; intraperitoneally) after induction of colitis. The lesions in the distal colon were scored at the macroscopic and microscopic level. Tissue malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity and collagen content were assessed and formation of reactive oxygen species and peroxynitrite was monitored by chemiluminescence (CL) assay. Trunk blood was collected for the measurement of serum tumor necrosis factor (TNF)-α level. Results.Treatment with SIM reduced the lesion score of the colitis group at macroscopic level (p<0.05), but there was no effect of treatment with FLU. The increase in colonic MDA level of the colitis group was reduced by both drugs at all doses (p<0.05–0.001). The decrease in GSH and the an increase in MPO activity in the colitis group were reversed by SIM at all doses (p<0.01), but FLU had no effect. An increase in colonic lucigenin CL value in the colitis group was reduced by SIM and FLU at all doses (p<0.001) and an increase in peroxynitrite ratio in the colitis group showed a significant reduction in SIM-treated groups; FLU reduced this effect at a dose of 1 mg/kg (p<0.01). An increase in tissue collagen content and serum TNF-α level in the colitis group was reversed by both drugs at all doses (p<0.001). Conclusions. SIM and FLU seemed to be beneficial in a TNBS-induced rat colitis model through the prevention of lipid peroxidation, superoxide generation, cytokine production and neutrophil accumulation.

1 November 2019 in Journal of Surgical Research
Verified
Journal Article
Closed access
ZKZarife Nigar Özdemir Kumral
Zarife Nigar Özdemir Kumral
BEBurak E. Erkek
Burak E. Erkek
BKBuse Karakuş
Buse Karakuş
MAMeslina Almacı
Meslina Almacı
RFReza Fathi
Reza Fathi
IAInci Alican
Inci Alican

20 February 2007 in Life Sciences
Verified
Journal Article
Closed access
NJNermina Jahovic
Nermina Jahovic
GEGözde Erkanlı
Gözde Erkanlı
SISevgin İşeri
Sevgin İşeri
SASerap Arbak
Serap Arbak
IAInci Alican
Inci Alican

1 September 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
BIBetül Esra İpEk
Betül Esra İpEk
MYMERAL Yuksel
MERAL Yuksel
ACAlev Cumbul
Alev Cumbul
FEFeriha Ercan
Feriha Ercan
HCHülya Cabadak
Hülya Cabadak
IAInci Alican
Inci Alican
Background: Previous studies found metformin as an effective agent to suppress oxidative stress, inflammation, and apoptosis in various inflammatory diseases. The present study investigated the effect of metformin against 2 experimental gastric injury models in rats, using macroscopical, histopathological, biochemical, and immunostaining studies. Methods: After 24 hours of fasting, male Sprague-Dawley rats (280-400 g) (n = 8 per group) received indomethacin (80 mg/kg; indo ulcer group) or absolute ethanol (5 mL/kg; ethanol ulcer group) or vehicle orally by gavage. Metformin (500 mg/kg) was given orally for 3 days prior to indomethacin or ethanol challenge. Ranitidine (50 mg/kg) was given orally for 3 days before indomethacin or ethanol administration as a positive control. On day 3, the animals were euthanized 6 hours after indo or 1 hour after ethanol challenge. Gastric samples were used for macroscopic scoring, histopathological examinations, and biochemical assays. Trunk blood was collected for the assessment of interleukin-1β level. Results: In both ethanol ulcer and indo ulcer groups, metformin decreased the extent of gastric lesions macroscopically and microscopically, improved the high chemiluminescence levels, and the percentage of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive apoptotic cells compared with untreated ulcer groups. Gastric blood flow analysis revealed significant increases in both metformin-treated ulcer groups compared to untreated ulcer groups. Conclusion: The findings of the present work demonstrated the gastroprotective effect of metformin against the development of gastric mucosal lesions induced by ethanol and indomethacin in non-diabetic, normoglycemic rats via its antioxidant and anti-apoptotic properties and partly from its ability to restore blood flow Cite this article as: İpek BE, Yüksel M, Cumbul A, et al. The effect of metformin on ethanol- and indomethacin-induced gastric ulcers in rats. Turk J Gastroenterol. 2022;33(9):767-776.